C1837624||Autonomic
C0302142||functional
C0302142||skeletal muscle
C0018798||cardiac abnormalities
C0243095||ergoreflex sensitivity
C0751651||mitochondrial disease
C0751651||Mitochondrial disease
C0751651||Mitochondrial disease
C0019247||genetic disorder
C0242692||skeletal muscles
C0878544||myocardial disease
C0034929||ergoreflex
C0242692||skeletal muscle
C1327622||regulates
C1321070||ventilatory
C0243095||ergoreflex sensitivity
C0751651||Mitochondrial disease
C0205161||abnormal
C1321070||ventilatory
C0243095||subclinical cardiac involvement
C0751651||Mitochondrial disease
C0025266||male
C1533847||skeletal myopathy
C0018799||cardiac disease
C0220825||evaluation
C1095989||BNPs
C3496493||galectin-3
C0201782||soluble suppression
C0007621||tumorigenesis 2
C0201782||soluble suppression of tumorigenesis 2
C0523952||troponin T/I
C0546632||catecholamines
C0013798||ECG
C0013798||24-h ECG recording
C2959886||cardiopulmonary exercise testing
C0013516||echocardiography
C0024485||cardiac/muscle magnetic resonance
C0024485||cardiac/muscle magnetic resonance
C0220825||ergoreflex assessment
C0026848||myopathic
C0243095||subclinical cardiac damage
C0442726||detected
C0016059||fibrosis
C0024485||CMR
C0243095||Ergoreflex sensitivity
C0521119||extracellular
C0024485||MMR
C0243095||ergoreflex sensitivity
C0243095||cardiac involvement
C0030055||oxygen consumption
C0030055||VO2
C3540840||ventilatory inefficiency
C0243095||Ergoreflex sensitivity
C0030055||VO2
C0262385||autonomic imbalance
C0032105||Plasma
C0028351||norepinephrine
C0151654||myocardial fibrosis
C1533847||Skeletal myopathy
C0751651||Mitochondrial disease
C0243095||ergoreflex sensitivity
C0243095||cardiac involvement
C0424551||exercise intolerance